2015
DOI: 10.3390/brainsci5030275
|View full text |Cite
|
Sign up to set email alerts
|

Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains

Abstract: Dystrophin-glycoprotein complex (DGC) is an important structural unit in skeletal muscle that connects the cytoskeleton (f-actin) of a muscle fiber to the extracellular matrix (ECM). Several muscular dystrophies, such as Duchenne muscular dystrophy, Becker muscular dystrophy, congenital muscular dystrophies (dystroglycanopathies), and limb-girdle muscular dystrophies (sarcoglycanopathies), are caused by mutations in the different DGC components. Although many early studies indicated DGC plays a crucial mechani… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
28
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 124 publications
(183 reference statements)
0
28
0
Order By: Relevance
“…Increased sarcoplasmic nNOS amount in the presence of intact or repaired sarcolemma, as suggested by evidence concerning α1-syntrophin KO mice or micro-dystrophin transgenic mdx mice [14,45], or firmly anchored nNOS to a defective sarcolemma [46] does not cause nitrosative stress and muscle degeneration. Indeed, the amount and spatiotemporal distribution of NO apparently regulate muscle plasticity insofar as transient activation of sarcolemmal nNOS positively regulates myofiber perfusion and size [2,47,48], whereas sustained sarcoplasmic activation promotes atrophy [9][10][11]. Our present results indicate increased superoxide anion released by mitochondria as the source responsible for active nNOS redistribution after 6 h unloading.…”
Section: Discussionmentioning
confidence: 70%
“…Increased sarcoplasmic nNOS amount in the presence of intact or repaired sarcolemma, as suggested by evidence concerning α1-syntrophin KO mice or micro-dystrophin transgenic mdx mice [14,45], or firmly anchored nNOS to a defective sarcolemma [46] does not cause nitrosative stress and muscle degeneration. Indeed, the amount and spatiotemporal distribution of NO apparently regulate muscle plasticity insofar as transient activation of sarcolemmal nNOS positively regulates myofiber perfusion and size [2,47,48], whereas sustained sarcoplasmic activation promotes atrophy [9][10][11]. Our present results indicate increased superoxide anion released by mitochondria as the source responsible for active nNOS redistribution after 6 h unloading.…”
Section: Discussionmentioning
confidence: 70%
“…DMD is caused by frameshift mutations leading to premature stop codons in the dystrophin (DMD ) gene, which precludes the synthesis of a protein called dystrophin23. Dystrophin, a large (427 kDa) actin-binding protein forms the dystrophin-glycoprotein complex (DGC) at the sarcolemma, in conjunction with dystrophin-associated proteins, such as dystroglycans, neuronal nitric oxide synthase, and sarcoglycans, to name a few45. Dystrophin deficiency perturbs the assembly of DGC and destabilizes the muscle membrane, making it more vulnerable to injury when exposed to stress during muscle contraction or stretch.…”
mentioning
confidence: 99%
“…DMD is caused by mutations in the DMD gene coding for dystrophin,1,6 a membrane-associated protein that links cytoskeletal actin in muscle fibers with the surrounding extracellular matrix by forming a network with sarcolemmal glycoproteins (otherwise known as the dystrophin-associated glycoprotein complex [DAGC]) 79. This linkage strengthens muscle structure during stressful contraction/relaxation cycles;10 recent studies, however, indicate that dystrophin also has nonmechanical roles 11. Dystrophin has four domains: an N-terminal domain for binding actin, a rod domain mainly for structural flexibility, a cysteine-rich domain for facilitating protein–protein interactions, and a C-terminal domain for binding DAGC proteins at the sarcolemma 9,12.…”
Section: Duchenne Muscular Dystrophy (Dmd): Introduction and Managemementioning
confidence: 99%